equinet AG set a €118.00 ($140.48) price objective on Bayer AG (FRA:BAYN) in a report published on Friday morning. The brokerage currently has a buy rating on the healthcare company’s stock.

Several other analysts have also weighed in on the stock. UBS AG set a €125.00 ($148.81) target price on shares of Bayer AG and gave the company a buy rating in a research report on Tuesday, August 29th. Independent Research GmbH set a €120.00 ($142.86) target price on shares of Bayer AG and gave the company a neutral rating in a research report on Wednesday, August 23rd. Kepler Capital Markets set a €105.00 ($125.00) target price on shares of Bayer AG and gave the company a neutral rating in a research report on Monday, July 3rd. Societe Generale set a €117.00 ($139.29) target price on shares of Bayer AG and gave the company a neutral rating in a research report on Tuesday, July 4th. Finally, Bank of America Corporation set a €140.00 ($166.67) target price on shares of Bayer AG and gave the company a buy rating in a research report on Monday, June 12th. Nine analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company presently has a consensus rating of Buy and a consensus target price of €119.32 ($142.05).

Bayer AG (FRA:BAYN) opened at 110.60 on Friday. The stock’s 50 day moving average is €108.06 and its 200 day moving average is €111.34. The company has a market cap of €96.46 billion and a PE ratio of 19.13. Bayer AG has a 12 month low of €85.72 and a 12 month high of €123.82.

WARNING: This news story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/19/bayer-ag-bayn-pt-set-at-118-00-by-equinet-ag.html.

About Bayer AG

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.